# A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)

> **NCT00914212** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 15 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Placebo
- **DRUG:** Comparator: sibutramine

## Key facts

- **NCT ID:** NCT00914212
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2015-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914212, "A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00914212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*